In vivo activity of piritrexim [corrected] against Toxoplasma gondii.
D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D051379:Mice; D011739:Pyrimethamine / Q000494:pharmacology; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D014122:Toxoplasma / Q000187:drug effects*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000469:parasitology
D000890:Anti-Infective Agents; D004338:Drug Combinations; D011743:Pyrimidines; D013411:Sulfadiazine; C023507:tetroxoprim; D011739:Pyrimethamine